Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Study of GSK2302024A Antigen-Specific Cancer Immunotherapeutic combined with standard neoadjuvant treatment in patients with WT1-positive primary inva


Collapse Overview 
Collapse sponsor award id
SK2302024A


Collapse Biography 

Collapse Time 
Collapse start date
2012-02-24

Collapse end date
2022-02-23